Nasal high‐flow therapy versus NIV in COPD patients with chronic respiratory failure скачать в хорошем качестве

Nasal high‐flow therapy versus NIV in COPD patients with chronic respiratory failure

To access the manuscript: https://onlinelibrary.wiley.com/doi/f... McKinstry, S, Singer, J, Baarsma, JP, Weatherall, M, Beasley, R, Fingleton, J. Nasal high‐flow therapy compared with non‐invasive ventilation in COPD patients with chronic respiratory failure: A randomized controlled cross‐over trial. Respirology. 2019; 1– 7. https://doi.org/10.1111/resp.13575 SUMMARY: Non‐invasive ventilation (NIV) reduces transcutaneous partial pressure of carbon dioxide (PtCO2) more than nasal high‐flow (NHF) therapy in hypercapnic COPD, but NHF is better tolerated. Video produced by the Medical Research Association of New Zealand (MRINZ). Medical Illustration by Dr Ciléin Kearns (Artibiotics).